as alternative to albuterol nebulizer/inhaler, terbutaline subQ or IV is being considered. Has anyone prepared and dispensed in Covid suspected/positive cases and if so, what outcomes can you share? thanks in advance.
jbrady@svmh.com

is anyone familiar with oxygen carrier blood products for Jehovah witness patients? hemopure or sanguinate are investigational and not available to order; however if anyone has experience with bloodless surgery alternatives and approaches, thank you in advance for sharing.
jbrady@svmh.com

https://www.regulations.gov/docket?D=CDC-2020-0046

The list is in draft form and public comments are due by June 30, 2020.

Hello All,
I would appreciate if you can share how IV loading doses of phenytoin are supplied and administered at your institutions (i.e. admixture vs undiluted). Thanks!

Chris

I am curious if other inpatient pharmacies stock sterile water for injection in automated dispensing cabinets to be used for reconstitution?

Our hospital would like to start giving tacrolimus via the SL route for patients unable to swallow the capsule.
Does anyone administer tacrolimus sublingually in their hospital and has a policy or process to share on how it is being administered, respecting that it is listed as a Group 2 hazardous medication on NIOSH's hazardous drug list?

Thank you! Alex

Hello,

Hi Everyone,
We are having multiple issues with air bubbles found in 1.2 micron intralipd filters. we have changed 3 different companies, but still having same issues. Has anyone else experienced this problem, and if there are any solutions?

How do you supply non-commercially available unit doses of meds for inhalation like amikacin - parenteral or sterile oral syringe w/aux label, other?

I believe doses need to be prepared in sterile containers which leaves few options. I am aware of the 2018 ISMP article but this isn't specifically addressed, and there weren't many responses to this in an older MSOS thread but I bet a lot of us deal with this.

Thanks!

Hello,

I am currently updating our Assessment of Risk for USP <800> and was wondering if anyone would be willing to share how they are addressing NIOSH table 2 drugs within the pharmacy (e.g., compounding, delivery). Are you treating all Table 2 medications the same?

Thanks in advance!